...Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) in a court-supervised bankruptcy auction. Synergy markets gastrointestinal drug Trulance plecanatide. Trulance...
...analog and guanylate cyclase C (GCC; GUCY2C) agonist. In November, Synergy said it expects 2018 Trulance...
...Quebec Business: Gastrointestinal Shannon Lehnbeuter Dolcanatide (SP-333) Trulance (Brand), SP-304 (Former compound #), guanilib (Former generic), plecanatide (Generic), Trulance...

...exploring options including bankruptcy as it expected to miss sales targets for gastrointestinal drug Trulance plecanatide...
...agreement, triggering early repayment and penalty fees. In December, it agreed to sell assets including Trulance...

...voretigene neparvovec-rzyl Biallelic RPE65 mutation-associated retinal dystrophy U.S. $15.6 Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) (B) Trulance plecanatide...

...Pharmaceuticals Inc. (NASDAQ:SGYP) in a court-supervised bankruptcy auction, including global rights to gastrointestinal drug Trulance plecanatide...
...for those assets. In November, Synergy said it expects 2018 Trulance sales of $42-$47 million. Trulance...
...Laval, Quebec Business: Gastrointestinal Shannon Lehnbeuter Trulance (Brand), SP-304 (Former compound #), guanilib (Former generic), plecanatide (Generic), Trulance...

...sales of gastrointestinal drug Trulance plecanatide. The company said it is projecting net sales for Trulance...
...a term loan agreement with healthcare investment firm CRG Servicing LLC. If net sales of Trulance...
...N.Y. Business: Gastrointestinal Jaime De Leon Trulance (Brand), SP-304 (Former compound #), guanilib (Former generic), plecanatide (Generic), Trulance...

...Group Stock Co. Ltd. (Linyi, China) exclusive rights to develop and commercialize gastrointestinal drug Trulance plecanatide...
...tiered royalties. Luoxin will be responsible for clinical development, regulatory approval and commercialization in China. Trulance...
...Linyi, China Business: Gastrointestinal Sandi Wong Trulance (Brand), SP-304 (Former compound #), guanilib (Former generic), plecanatide (Generic), Trulance...

...Group Stock Co. Ltd. (Linyi, China) exclusive rights to develop and commercialize gastrointestinal drug Trulance plecanatide...
...tiered royalties. Luoxin will be responsible for clinical development, regulatory approval and commercialization in China. Trulance...
...to $1.63 on Tuesday. Sandi Wong Trulance (Brand), SP-304 (Former compound #), guanilib (Former generic), plecanatide (Generic), Trulance...

...Trulance plecanatide, a uroguanylin analog and GCC agonist. In a pooled analysis across the trials, Trulance...

...Access Meter scores correlate with commercial performance for drugs launched in 2017. For example, Trulance plecanatide...
...the chronic constipation drug from Synergy Pharmaceuticals Inc., and Radius’ Tymlos for osteoporosis, struggled commercially. Trulance...
...sales of Trulance plecanatide of $16.8 million and 1Q18 sales of $6.8 million. FDA approved Trulance...

...Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) said FDA approved Trulance plecanatide to treat irritable bowel syndrome with constipation...
...CIC). Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), New York, N.Y. Product: Trulance plecanatide (formerly SP-304) Business: Gastrointestinal Chris Lieu plecanatide Trulance Synergy...